From the Research
Beta blockers should not be used as a first-line treatment for anxiety disorders due to the lack of robust evidence supporting their effectiveness, as shown in the most recent and highest quality study 1.
Key Points to Consider
- The use of beta blockers for anxiety has been increasing, but there is limited evidence to support their effectiveness in treating anxiety disorders.
- A systematic review and meta-analysis published in 2025 found no evidence for a beneficial effect of beta blockers compared to placebo or benzodiazepines in patients with social phobia or panic disorder with/without agoraphobia 1.
- The study suggested that beta blockers may not be an effective treatment for anxiety disorders, and their use should be approached with caution.
- Other studies have shown that beta blockers may be effective in reducing physical symptoms of anxiety, such as tremors and palpitations, but they do not address the psychological aspects of anxiety 2, 3.
- The dosage and usage of beta blockers for anxiety vary, but typical doses range from 10-40 mg, taken 30-60 minutes before anxiety-provoking situations.
Important Considerations
- Beta blockers should be avoided in people with certain conditions, including asthma, diabetes, and some heart conditions.
- Potential side effects of beta blockers include fatigue, dizziness, and cold extremities.
- Beta blockers should not be stopped abruptly, as this can cause rebound effects; instead, they should be tapered off under medical supervision.
- Other treatment options, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs), may be more effective in treating anxiety disorders, as shown in a systematic review and meta-analysis published in 2019 4.